Patents by Inventor Marshall W. Huston

Marshall W. Huston has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR THE TREATMENT OF FABRY DISEASE
    Publication number: 20220273819
    Abstract: Nucleases and methods of using these nucleases for inserting a sequence encoding a therapeutic ?-Gal A protein such as an enzyme into a cell, thereby providing proteins or cell therapeutics for treatment and/or prevention of Fabry disease.
    Type: Application
    Filed: January 10, 2022
    Publication date: September 1, 2022
    Applicant: Sangamo Therapeutics, Inc.
    Inventor: Marshall W. HUSTON
  • Methods and compositions for the treatment of Fabry disease
    Patent number: 11219695
    Abstract: Nucleases and methods of using these nucleases for inserting a sequence encoding a therapeutic ?-Gal A protein such as an enzyme into a cell, thereby providing proteins or cell therapeutics for treatment and/or prevention of Fabry disease.
    Type: Grant
    Filed: October 19, 2017
    Date of Patent: January 11, 2022
    Assignee: Sangamo Therapeutics, Inc.
    Inventor: Marshall W. Huston
  • METHODS AND COMPOSITIONS FOR THE TREATMENT OF FABRY DISEASE
    Publication number: 20200239911
    Abstract: The present disclosure provides expression constructs comprising a GLA transgene encoding the at least one ?-Gal A protein for use in expressing ?-Gal A proteins and preventing, inhibiting or treating Fabry disease or one or more symptoms associated with Fabry disease.
    Type: Application
    Filed: January 3, 2020
    Publication date: July 30, 2020
    Inventor: Marshall W. Huston
  • METHODS AND COMPOSITIONS FOR THE TREATMENT OF FABRY DISEASE
    Publication number: 20180117181
    Abstract: Nucleases and methods of using these nucleases for inserting a sequence encoding a therapeutic ?-Gal A protein such as an enzyme into a cell, thereby providing proteins or cell therapeutics for treatment and/or prevention of Fabry disease.
    Type: Application
    Filed: October 19, 2017
    Publication date: May 3, 2018
    Inventor: Marshall W. Huston